nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2C8—Simvastatin—atherosclerosis	0.0521	0.0754	CbGbCtD
Propafenone—CYP2C8—Pravastatin—atherosclerosis	0.051	0.0738	CbGbCtD
Propafenone—CYP2C8—Lovastatin—atherosclerosis	0.051	0.0738	CbGbCtD
Propafenone—CYP2D6—Niacin—atherosclerosis	0.0421	0.0608	CbGbCtD
Propafenone—CYP2C9—Rosuvastatin—atherosclerosis	0.0391	0.0566	CbGbCtD
Propafenone—ABCB1—Ezetimibe—atherosclerosis	0.0379	0.0549	CbGbCtD
Propafenone—CYP2C9—Simvastatin—atherosclerosis	0.0364	0.0526	CbGbCtD
Propafenone—CYP2C9—Pravastatin—atherosclerosis	0.0356	0.0515	CbGbCtD
Propafenone—CYP2C9—Lovastatin—atherosclerosis	0.0356	0.0515	CbGbCtD
Propafenone—ABCB1—Simvastatin—atherosclerosis	0.0353	0.051	CbGbCtD
Propafenone—ABCB1—Lovastatin—atherosclerosis	0.0345	0.0499	CbGbCtD
Propafenone—ABCB1—Pravastatin—atherosclerosis	0.0345	0.0499	CbGbCtD
Propafenone—CYP2D6—Simvastatin—atherosclerosis	0.0332	0.0481	CbGbCtD
Propafenone—CYP2D6—Pravastatin—atherosclerosis	0.0325	0.0471	CbGbCtD
Propafenone—CYP2D6—Lovastatin—atherosclerosis	0.0325	0.0471	CbGbCtD
Propafenone—CYP3A4—Ezetimibe—atherosclerosis	0.0227	0.0329	CbGbCtD
Propafenone—CYP3A4—Rosuvastatin—atherosclerosis	0.0227	0.0329	CbGbCtD
Propafenone—CYP3A4—Simvastatin—atherosclerosis	0.0211	0.0306	CbGbCtD
Propafenone—CYP3A4—Lovastatin—atherosclerosis	0.0207	0.0299	CbGbCtD
Propafenone—CYP3A4—Pravastatin—atherosclerosis	0.0207	0.0299	CbGbCtD
Propafenone—Carvedilol—SELE—atherosclerosis	0.0016	0.249	CrCbGaD
Propafenone—Carvedilol—VCAM1—atherosclerosis	0.00153	0.238	CrCbGaD
Propafenone—Benazepril—MTHFR—atherosclerosis	0.000681	0.106	CrCbGaD
Propafenone—Quinapril—ACE—atherosclerosis	0.000638	0.0993	CrCbGaD
Propafenone—Benazepril—ACE—atherosclerosis	0.000555	0.0864	CrCbGaD
Propafenone—Carvedilol—VEGFA—atherosclerosis	0.000516	0.0803	CrCbGaD
Propafenone—Mental disorder—Simvastatin—atherosclerosis	0.000394	0.00157	CcSEcCtD
Propafenone—Tremor—Lovastatin—atherosclerosis	0.000392	0.00156	CcSEcCtD
Propafenone—Visual impairment—Pravastatin—atherosclerosis	0.000392	0.00156	CcSEcCtD
Propafenone—Erythema—Simvastatin—atherosclerosis	0.000392	0.00156	CcSEcCtD
Propafenone—Ill-defined disorder—Lovastatin—atherosclerosis	0.000389	0.00155	CcSEcCtD
Propafenone—Eye disorder—Niacin—atherosclerosis	0.000386	0.00154	CcSEcCtD
Propafenone—Flatulence—Simvastatin—atherosclerosis	0.000386	0.00154	CcSEcCtD
Propafenone—Tinnitus—Niacin—atherosclerosis	0.000385	0.00154	CcSEcCtD
Propafenone—Dysgeusia—Simvastatin—atherosclerosis	0.000384	0.00153	CcSEcCtD
Propafenone—Flushing—Niacin—atherosclerosis	0.000384	0.00153	CcSEcCtD
Propafenone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000381	0.00152	CcSEcCtD
Propafenone—Anaemia—Ezetimibe—atherosclerosis	0.00038	0.00151	CcSEcCtD
Propafenone—Tinnitus—Pravastatin—atherosclerosis	0.000379	0.00151	CcSEcCtD
Propafenone—Malaise—Lovastatin—atherosclerosis	0.000378	0.00151	CcSEcCtD
Propafenone—Cardiac disorder—Pravastatin—atherosclerosis	0.000378	0.0015	CcSEcCtD
Propafenone—Flushing—Pravastatin—atherosclerosis	0.000378	0.0015	CcSEcCtD
Propafenone—Muscle spasms—Simvastatin—atherosclerosis	0.000377	0.0015	CcSEcCtD
Propafenone—Vertigo—Lovastatin—atherosclerosis	0.000376	0.0015	CcSEcCtD
Propafenone—Angiopathy—Niacin—atherosclerosis	0.000375	0.00149	CcSEcCtD
Propafenone—Leukopenia—Lovastatin—atherosclerosis	0.000375	0.00149	CcSEcCtD
Propafenone—Malaise—Ezetimibe—atherosclerosis	0.00037	0.00148	CcSEcCtD
Propafenone—Vision blurred—Simvastatin—atherosclerosis	0.000369	0.00147	CcSEcCtD
Propafenone—Arrhythmia—Niacin—atherosclerosis	0.000369	0.00147	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000368	0.00146	CcSEcCtD
Propafenone—Tremor—Simvastatin—atherosclerosis	0.000367	0.00146	CcSEcCtD
Propafenone—Alopecia—Niacin—atherosclerosis	0.000365	0.00146	CcSEcCtD
Propafenone—Insomnia—Rosuvastatin—atherosclerosis	0.000365	0.00145	CcSEcCtD
Propafenone—Ill-defined disorder—Simvastatin—atherosclerosis	0.000364	0.00145	CcSEcCtD
Propafenone—Arrhythmia—Pravastatin—atherosclerosis	0.000364	0.00145	CcSEcCtD
Propafenone—Palpitations—Ezetimibe—atherosclerosis	0.000363	0.00145	CcSEcCtD
Propafenone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000362	0.00144	CcSEcCtD
Propafenone—Anaemia—Simvastatin—atherosclerosis	0.000362	0.00144	CcSEcCtD
Propafenone—Malnutrition—Niacin—atherosclerosis	0.00036	0.00143	CcSEcCtD
Propafenone—Erythema—Niacin—atherosclerosis	0.00036	0.00143	CcSEcCtD
Propafenone—Alopecia—Pravastatin—atherosclerosis	0.00036	0.00143	CcSEcCtD
Propafenone—Cough—Ezetimibe—atherosclerosis	0.000359	0.00143	CcSEcCtD
Propafenone—Chest pain—Lovastatin—atherosclerosis	0.000357	0.00142	CcSEcCtD
Propafenone—Myalgia—Lovastatin—atherosclerosis	0.000357	0.00142	CcSEcCtD
Propafenone—Anxiety—Lovastatin—atherosclerosis	0.000355	0.00142	CcSEcCtD
Propafenone—Dyspepsia—Rosuvastatin—atherosclerosis	0.000355	0.00141	CcSEcCtD
Propafenone—Hypertension—Ezetimibe—atherosclerosis	0.000355	0.00141	CcSEcCtD
Propafenone—Flatulence—Niacin—atherosclerosis	0.000354	0.00141	CcSEcCtD
Propafenone—Malaise—Simvastatin—atherosclerosis	0.000353	0.00141	CcSEcCtD
Propafenone—Tension—Niacin—atherosclerosis	0.000353	0.00141	CcSEcCtD
Propafenone—Discomfort—Lovastatin—atherosclerosis	0.000352	0.0014	CcSEcCtD
Propafenone—Vertigo—Simvastatin—atherosclerosis	0.000352	0.0014	CcSEcCtD
Propafenone—Leukopenia—Simvastatin—atherosclerosis	0.000351	0.0014	CcSEcCtD
Propafenone—Chest pain—Ezetimibe—atherosclerosis	0.00035	0.00139	CcSEcCtD
Propafenone—Myalgia—Ezetimibe—atherosclerosis	0.00035	0.00139	CcSEcCtD
Propafenone—Nervousness—Niacin—atherosclerosis	0.000349	0.00139	CcSEcCtD
Propafenone—Flatulence—Pravastatin—atherosclerosis	0.000349	0.00139	CcSEcCtD
Propafenone—Dry mouth—Lovastatin—atherosclerosis	0.000349	0.00139	CcSEcCtD
Propafenone—Tension—Pravastatin—atherosclerosis	0.000348	0.00138	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000347	0.00138	CcSEcCtD
Propafenone—Dysgeusia—Pravastatin—atherosclerosis	0.000347	0.00138	CcSEcCtD
Propafenone—Muscle spasms—Niacin—atherosclerosis	0.000346	0.00138	CcSEcCtD
Propafenone—Discomfort—Ezetimibe—atherosclerosis	0.000346	0.00138	CcSEcCtD
Propafenone—Constipation—Rosuvastatin—atherosclerosis	0.000345	0.00137	CcSEcCtD
Propafenone—Pain—Rosuvastatin—atherosclerosis	0.000345	0.00137	CcSEcCtD
Propafenone—Mirabegron—ALB—atherosclerosis	0.000345	0.0537	CrCbGaD
Propafenone—Confusional state—Lovastatin—atherosclerosis	0.000345	0.00137	CcSEcCtD
Propafenone—Nervousness—Pravastatin—atherosclerosis	0.000344	0.00137	CcSEcCtD
Propafenone—Dry mouth—Ezetimibe—atherosclerosis	0.000342	0.00136	CcSEcCtD
Propafenone—Muscle spasms—Pravastatin—atherosclerosis	0.000341	0.00136	CcSEcCtD
Propafenone—Infection—Lovastatin—atherosclerosis	0.00034	0.00135	CcSEcCtD
Propafenone—Vision blurred—Niacin—atherosclerosis	0.000339	0.00135	CcSEcCtD
Propafenone—Confusional state—Ezetimibe—atherosclerosis	0.000338	0.00135	CcSEcCtD
Propafenone—Thrombocytopenia—Lovastatin—atherosclerosis	0.000335	0.00133	CcSEcCtD
Propafenone—Vision blurred—Pravastatin—atherosclerosis	0.000334	0.00133	CcSEcCtD
Propafenone—Chest pain—Simvastatin—atherosclerosis	0.000334	0.00133	CcSEcCtD
Propafenone—Myalgia—Simvastatin—atherosclerosis	0.000334	0.00133	CcSEcCtD
Propafenone—Infection—Ezetimibe—atherosclerosis	0.000333	0.00133	CcSEcCtD
Propafenone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000332	0.00132	CcSEcCtD
Propafenone—Anxiety—Simvastatin—atherosclerosis	0.000332	0.00132	CcSEcCtD
Propafenone—Tremor—Pravastatin—atherosclerosis	0.000332	0.00132	CcSEcCtD
Propafenone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00033	0.00131	CcSEcCtD
Propafenone—Discomfort—Simvastatin—atherosclerosis	0.00033	0.00131	CcSEcCtD
Propafenone—Nervous system disorder—Ezetimibe—atherosclerosis	0.000329	0.00131	CcSEcCtD
Propafenone—Ill-defined disorder—Pravastatin—atherosclerosis	0.000329	0.00131	CcSEcCtD
Propafenone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000328	0.00131	CcSEcCtD
Propafenone—Anaemia—Pravastatin—atherosclerosis	0.000327	0.0013	CcSEcCtD
Propafenone—Anorexia—Lovastatin—atherosclerosis	0.000326	0.0013	CcSEcCtD
Propafenone—Skin disorder—Ezetimibe—atherosclerosis	0.000326	0.0013	CcSEcCtD
Propafenone—Vertigo—Niacin—atherosclerosis	0.000323	0.00129	CcSEcCtD
Propafenone—Syncope—Niacin—atherosclerosis	0.000323	0.00129	CcSEcCtD
Propafenone—Confusional state—Simvastatin—atherosclerosis	0.000322	0.00128	CcSEcCtD
Propafenone—Leukopenia—Niacin—atherosclerosis	0.000322	0.00128	CcSEcCtD
Propafenone—Urticaria—Rosuvastatin—atherosclerosis	0.00032	0.00128	CcSEcCtD
Propafenone—Oedema—Simvastatin—atherosclerosis	0.00032	0.00127	CcSEcCtD
Propafenone—Malaise—Pravastatin—atherosclerosis	0.000319	0.00127	CcSEcCtD
Propafenone—Abdominal pain—Rosuvastatin—atherosclerosis	0.000319	0.00127	CcSEcCtD
Propafenone—Vertigo—Pravastatin—atherosclerosis	0.000318	0.00127	CcSEcCtD
Propafenone—Palpitations—Niacin—atherosclerosis	0.000318	0.00127	CcSEcCtD
Propafenone—Infection—Simvastatin—atherosclerosis	0.000318	0.00127	CcSEcCtD
Propafenone—Leukopenia—Pravastatin—atherosclerosis	0.000317	0.00126	CcSEcCtD
Propafenone—Loss of consciousness—Niacin—atherosclerosis	0.000316	0.00126	CcSEcCtD
Propafenone—Cough—Niacin—atherosclerosis	0.000314	0.00125	CcSEcCtD
Propafenone—Thrombocytopenia—Simvastatin—atherosclerosis	0.000313	0.00125	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000311	0.00124	CcSEcCtD
Propafenone—Insomnia—Lovastatin—atherosclerosis	0.000309	0.00123	CcSEcCtD
Propafenone—Cough—Pravastatin—atherosclerosis	0.000309	0.00123	CcSEcCtD
Propafenone—Paraesthesia—Lovastatin—atherosclerosis	0.000307	0.00122	CcSEcCtD
Propafenone—Myalgia—Niacin—atherosclerosis	0.000306	0.00122	CcSEcCtD
Propafenone—Hypertension—Pravastatin—atherosclerosis	0.000306	0.00122	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000305	0.00122	CcSEcCtD
Propafenone—Anorexia—Simvastatin—atherosclerosis	0.000305	0.00121	CcSEcCtD
Propafenone—Dyspnoea—Lovastatin—atherosclerosis	0.000305	0.00121	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000304	0.00121	CcSEcCtD
Propafenone—Insomnia—Ezetimibe—atherosclerosis	0.000303	0.00121	CcSEcCtD
Propafenone—Chest pain—Pravastatin—atherosclerosis	0.000302	0.0012	CcSEcCtD
Propafenone—Myalgia—Pravastatin—atherosclerosis	0.000302	0.0012	CcSEcCtD
Propafenone—Paraesthesia—Ezetimibe—atherosclerosis	0.000301	0.0012	CcSEcCtD
Propafenone—Dyspepsia—Lovastatin—atherosclerosis	0.000301	0.0012	CcSEcCtD
Propafenone—Anxiety—Pravastatin—atherosclerosis	0.000301	0.0012	CcSEcCtD
Propafenone—Dry mouth—Niacin—atherosclerosis	0.0003	0.00119	CcSEcCtD
Propafenone—Dyspnoea—Ezetimibe—atherosclerosis	0.000299	0.00119	CcSEcCtD
Propafenone—Discomfort—Pravastatin—atherosclerosis	0.000298	0.00119	CcSEcCtD
Propafenone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000297	0.00118	CcSEcCtD
Propafenone—Decreased appetite—Lovastatin—atherosclerosis	0.000297	0.00118	CcSEcCtD
Propafenone—Dyspepsia—Ezetimibe—atherosclerosis	0.000295	0.00118	CcSEcCtD
Propafenone—Fatigue—Lovastatin—atherosclerosis	0.000295	0.00117	CcSEcCtD
Propafenone—Oedema—Niacin—atherosclerosis	0.000294	0.00117	CcSEcCtD
Propafenone—Constipation—Lovastatin—atherosclerosis	0.000292	0.00116	CcSEcCtD
Propafenone—Pain—Lovastatin—atherosclerosis	0.000292	0.00116	CcSEcCtD
Propafenone—Confusional state—Pravastatin—atherosclerosis	0.000291	0.00116	CcSEcCtD
Propafenone—Decreased appetite—Ezetimibe—atherosclerosis	0.000291	0.00116	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000291	0.00116	CcSEcCtD
Propafenone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000289	0.00115	CcSEcCtD
Propafenone—Asthenia—Rosuvastatin—atherosclerosis	0.000289	0.00115	CcSEcCtD
Propafenone—Insomnia—Simvastatin—atherosclerosis	0.000289	0.00115	CcSEcCtD
Propafenone—Oedema—Pravastatin—atherosclerosis	0.000289	0.00115	CcSEcCtD
Propafenone—Fatigue—Ezetimibe—atherosclerosis	0.000289	0.00115	CcSEcCtD
Propafenone—Shock—Niacin—atherosclerosis	0.000289	0.00115	CcSEcCtD
Propafenone—Infection—Pravastatin—atherosclerosis	0.000287	0.00114	CcSEcCtD
Propafenone—Paraesthesia—Simvastatin—atherosclerosis	0.000287	0.00114	CcSEcCtD
Propafenone—Pain—Ezetimibe—atherosclerosis	0.000287	0.00114	CcSEcCtD
Propafenone—Constipation—Ezetimibe—atherosclerosis	0.000287	0.00114	CcSEcCtD
Propafenone—Tachycardia—Niacin—atherosclerosis	0.000287	0.00114	CcSEcCtD
Propafenone—Pruritus—Rosuvastatin—atherosclerosis	0.000285	0.00114	CcSEcCtD
Propafenone—Skin disorder—Niacin—atherosclerosis	0.000285	0.00114	CcSEcCtD
Propafenone—Dyspnoea—Simvastatin—atherosclerosis	0.000285	0.00114	CcSEcCtD
Propafenone—Hyperhidrosis—Niacin—atherosclerosis	0.000284	0.00113	CcSEcCtD
Propafenone—Thrombocytopenia—Pravastatin—atherosclerosis	0.000283	0.00113	CcSEcCtD
Propafenone—Feeling abnormal—Lovastatin—atherosclerosis	0.000282	0.00112	CcSEcCtD
Propafenone—Dyspepsia—Simvastatin—atherosclerosis	0.000281	0.00112	CcSEcCtD
Propafenone—Anorexia—Niacin—atherosclerosis	0.00028	0.00112	CcSEcCtD
Propafenone—Salsalate—PTGS2—atherosclerosis	0.00028	0.0436	CrCbGaD
Propafenone—Oxaprozin—PTGS2—atherosclerosis	0.00028	0.0436	CrCbGaD
Propafenone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00028	0.00111	CcSEcCtD
Propafenone—Hyperhidrosis—Pravastatin—atherosclerosis	0.000279	0.00111	CcSEcCtD
Propafenone—Decreased appetite—Simvastatin—atherosclerosis	0.000278	0.00111	CcSEcCtD
Propafenone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000276	0.0011	CcSEcCtD
Propafenone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000276	0.0011	CcSEcCtD
Propafenone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000276	0.0011	CcSEcCtD
Propafenone—Fatigue—Simvastatin—atherosclerosis	0.000276	0.0011	CcSEcCtD
Propafenone—Anorexia—Pravastatin—atherosclerosis	0.000276	0.0011	CcSEcCtD
Propafenone—Hypotension—Niacin—atherosclerosis	0.000274	0.00109	CcSEcCtD
Propafenone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000274	0.00109	CcSEcCtD
Propafenone—Constipation—Simvastatin—atherosclerosis	0.000273	0.00109	CcSEcCtD
Propafenone—Pain—Simvastatin—atherosclerosis	0.000273	0.00109	CcSEcCtD
Propafenone—Urticaria—Lovastatin—atherosclerosis	0.000272	0.00108	CcSEcCtD
Propafenone—Abdominal pain—Lovastatin—atherosclerosis	0.00027	0.00108	CcSEcCtD
Propafenone—Body temperature increased—Lovastatin—atherosclerosis	0.00027	0.00108	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000267	0.00107	CcSEcCtD
Propafenone—Dizziness—Rosuvastatin—atherosclerosis	0.000267	0.00106	CcSEcCtD
Propafenone—Urticaria—Ezetimibe—atherosclerosis	0.000266	0.00106	CcSEcCtD
Propafenone—Insomnia—Niacin—atherosclerosis	0.000266	0.00106	CcSEcCtD
Propafenone—Abdominal pain—Ezetimibe—atherosclerosis	0.000265	0.00106	CcSEcCtD
Propafenone—Body temperature increased—Ezetimibe—atherosclerosis	0.000265	0.00106	CcSEcCtD
Propafenone—Paraesthesia—Niacin—atherosclerosis	0.000264	0.00105	CcSEcCtD
Propafenone—Feeling abnormal—Simvastatin—atherosclerosis	0.000263	0.00105	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000263	0.00105	CcSEcCtD
Propafenone—Dyspnoea—Niacin—atherosclerosis	0.000262	0.00104	CcSEcCtD
Propafenone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000261	0.00104	CcSEcCtD
Propafenone—Insomnia—Pravastatin—atherosclerosis	0.000261	0.00104	CcSEcCtD
Propafenone—Somnolence—Niacin—atherosclerosis	0.000261	0.00104	CcSEcCtD
Propafenone—Paraesthesia—Pravastatin—atherosclerosis	0.00026	0.00103	CcSEcCtD
Propafenone—Dyspepsia—Niacin—atherosclerosis	0.000258	0.00103	CcSEcCtD
Propafenone—Dyspnoea—Pravastatin—atherosclerosis	0.000258	0.00103	CcSEcCtD
Propafenone—Decreased appetite—Niacin—atherosclerosis	0.000255	0.00102	CcSEcCtD
Propafenone—Dyspepsia—Pravastatin—atherosclerosis	0.000254	0.00101	CcSEcCtD
Propafenone—Rash—Rosuvastatin—atherosclerosis	0.000254	0.00101	CcSEcCtD
Propafenone—Dermatitis—Rosuvastatin—atherosclerosis	0.000254	0.00101	CcSEcCtD
Propafenone—Urticaria—Simvastatin—atherosclerosis	0.000254	0.00101	CcSEcCtD
Propafenone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000253	0.00101	CcSEcCtD
Propafenone—Abdominal pain—Simvastatin—atherosclerosis	0.000253	0.00101	CcSEcCtD
Propafenone—Body temperature increased—Simvastatin—atherosclerosis	0.000253	0.00101	CcSEcCtD
Propafenone—Headache—Rosuvastatin—atherosclerosis	0.000253	0.00101	CcSEcCtD
Propafenone—Hypersensitivity—Lovastatin—atherosclerosis	0.000252	0.001	CcSEcCtD
Propafenone—Decreased appetite—Pravastatin—atherosclerosis	0.000251	0.001	CcSEcCtD
Propafenone—Pain—Niacin—atherosclerosis	0.000251	0.001	CcSEcCtD
Propafenone—Fatigue—Pravastatin—atherosclerosis	0.000249	0.000993	CcSEcCtD
Propafenone—Constipation—Pravastatin—atherosclerosis	0.000247	0.000985	CcSEcCtD
Propafenone—Pain—Pravastatin—atherosclerosis	0.000247	0.000985	CcSEcCtD
Propafenone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000247	0.000984	CcSEcCtD
Propafenone—Asthenia—Lovastatin—atherosclerosis	0.000245	0.000977	CcSEcCtD
Propafenone—Pruritus—Lovastatin—atherosclerosis	0.000242	0.000964	CcSEcCtD
Propafenone—Asthenia—Ezetimibe—atherosclerosis	0.000241	0.000959	CcSEcCtD
Propafenone—Gastrointestinal pain—Niacin—atherosclerosis	0.00024	0.000957	CcSEcCtD
Propafenone—Nausea—Rosuvastatin—atherosclerosis	0.00024	0.000955	CcSEcCtD
Propafenone—Feeling abnormal—Pravastatin—atherosclerosis	0.000238	0.000949	CcSEcCtD
Propafenone—Pruritus—Ezetimibe—atherosclerosis	0.000237	0.000945	CcSEcCtD
Propafenone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000236	0.000942	CcSEcCtD
Propafenone—Hypersensitivity—Simvastatin—atherosclerosis	0.000236	0.000939	CcSEcCtD
Propafenone—Diarrhoea—Lovastatin—atherosclerosis	0.000234	0.000932	CcSEcCtD
Propafenone—Urticaria—Niacin—atherosclerosis	0.000233	0.000929	CcSEcCtD
Propafenone—Body temperature increased—Niacin—atherosclerosis	0.000232	0.000925	CcSEcCtD
Propafenone—Abdominal pain—Niacin—atherosclerosis	0.000232	0.000925	CcSEcCtD
Propafenone—Urticaria—Pravastatin—atherosclerosis	0.00023	0.000915	CcSEcCtD
Propafenone—Asthenia—Simvastatin—atherosclerosis	0.000229	0.000914	CcSEcCtD
Propafenone—Diarrhoea—Ezetimibe—atherosclerosis	0.000229	0.000914	CcSEcCtD
Propafenone—Body temperature increased—Pravastatin—atherosclerosis	0.000229	0.000911	CcSEcCtD
Propafenone—Abdominal pain—Pravastatin—atherosclerosis	0.000229	0.000911	CcSEcCtD
Propafenone—Pruritus—Simvastatin—atherosclerosis	0.000226	0.000901	CcSEcCtD
Propafenone—Dizziness—Lovastatin—atherosclerosis	0.000226	0.000901	CcSEcCtD
Propafenone—Dizziness—Ezetimibe—atherosclerosis	0.000222	0.000883	CcSEcCtD
Propafenone—Diarrhoea—Simvastatin—atherosclerosis	0.000219	0.000872	CcSEcCtD
Propafenone—Vomiting—Lovastatin—atherosclerosis	0.000217	0.000866	CcSEcCtD
Propafenone—Hypersensitivity—Niacin—atherosclerosis	0.000216	0.000862	CcSEcCtD
Propafenone—Rash—Lovastatin—atherosclerosis	0.000216	0.000859	CcSEcCtD
Propafenone—Dermatitis—Lovastatin—atherosclerosis	0.000215	0.000858	CcSEcCtD
Propafenone—Headache—Lovastatin—atherosclerosis	0.000214	0.000853	CcSEcCtD
Propafenone—Vomiting—Ezetimibe—atherosclerosis	0.000213	0.000849	CcSEcCtD
Propafenone—Hypersensitivity—Pravastatin—atherosclerosis	0.000213	0.000849	CcSEcCtD
Propafenone—Dizziness—Simvastatin—atherosclerosis	0.000211	0.000842	CcSEcCtD
Propafenone—Rash—Ezetimibe—atherosclerosis	0.000211	0.000842	CcSEcCtD
Propafenone—Dermatitis—Ezetimibe—atherosclerosis	0.000211	0.000842	CcSEcCtD
Propafenone—Asthenia—Niacin—atherosclerosis	0.000211	0.000839	CcSEcCtD
Propafenone—Headache—Ezetimibe—atherosclerosis	0.00021	0.000837	CcSEcCtD
Propafenone—Pruritus—Niacin—atherosclerosis	0.000208	0.000828	CcSEcCtD
Propafenone—Asthenia—Pravastatin—atherosclerosis	0.000207	0.000826	CcSEcCtD
Propafenone—Pruritus—Pravastatin—atherosclerosis	0.000205	0.000815	CcSEcCtD
Propafenone—Vomiting—Simvastatin—atherosclerosis	0.000203	0.00081	CcSEcCtD
Propafenone—Nausea—Lovastatin—atherosclerosis	0.000203	0.000809	CcSEcCtD
Propafenone—Rash—Simvastatin—atherosclerosis	0.000202	0.000803	CcSEcCtD
Propafenone—Dermatitis—Simvastatin—atherosclerosis	0.000201	0.000803	CcSEcCtD
Propafenone—Diarrhoea—Niacin—atherosclerosis	0.000201	0.0008	CcSEcCtD
Propafenone—Headache—Simvastatin—atherosclerosis	0.0002	0.000798	CcSEcCtD
Propafenone—Nausea—Ezetimibe—atherosclerosis	0.000199	0.000794	CcSEcCtD
Propafenone—Diarrhoea—Pravastatin—atherosclerosis	0.000198	0.000788	CcSEcCtD
Propafenone—Dizziness—Niacin—atherosclerosis	0.000194	0.000774	CcSEcCtD
Propafenone—Dizziness—Pravastatin—atherosclerosis	0.000191	0.000762	CcSEcCtD
Propafenone—Nausea—Simvastatin—atherosclerosis	0.00019	0.000757	CcSEcCtD
Propafenone—Vomiting—Niacin—atherosclerosis	0.000187	0.000744	CcSEcCtD
Propafenone—Rash—Niacin—atherosclerosis	0.000185	0.000738	CcSEcCtD
Propafenone—Dermatitis—Niacin—atherosclerosis	0.000185	0.000737	CcSEcCtD
Propafenone—Headache—Niacin—atherosclerosis	0.000184	0.000733	CcSEcCtD
Propafenone—Vomiting—Pravastatin—atherosclerosis	0.000184	0.000732	CcSEcCtD
Propafenone—Rash—Pravastatin—atherosclerosis	0.000182	0.000726	CcSEcCtD
Propafenone—Dermatitis—Pravastatin—atherosclerosis	0.000182	0.000726	CcSEcCtD
Propafenone—Headache—Pravastatin—atherosclerosis	0.000181	0.000722	CcSEcCtD
Propafenone—Nausea—Niacin—atherosclerosis	0.000174	0.000695	CcSEcCtD
Propafenone—Nausea—Pravastatin—atherosclerosis	0.000172	0.000684	CcSEcCtD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.36e-05	0.000266	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.36e-05	0.000266	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.36e-05	0.000265	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.35e-05	0.000263	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.34e-05	0.000262	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.34e-05	0.00026	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.33e-05	0.000259	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.32e-05	0.000258	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.32e-05	0.000258	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.32e-05	0.000257	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SCARB1—atherosclerosis	1.32e-05	0.000257	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.32e-05	0.000257	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.32e-05	0.000256	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.31e-05	0.000255	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.31e-05	0.000255	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.31e-05	0.000255	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOA2—atherosclerosis	1.31e-05	0.000255	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.3e-05	0.000254	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.3e-05	0.000252	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.29e-05	0.000252	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.29e-05	0.00025	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.28e-05	0.000249	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.27e-05	0.000248	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.27e-05	0.000247	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.26e-05	0.000245	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NAMPT—atherosclerosis	1.25e-05	0.000244	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LPA—atherosclerosis	1.25e-05	0.000244	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.25e-05	0.000243	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.25e-05	0.000243	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LIPC—atherosclerosis	1.24e-05	0.000243	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOC3—atherosclerosis	1.24e-05	0.000241	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LDLR—atherosclerosis	1.23e-05	0.00024	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.22e-05	0.000238	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BGN—atherosclerosis	1.21e-05	0.000236	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.21e-05	0.000235	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.2e-05	0.000234	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CETP—atherosclerosis	1.2e-05	0.000234	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOA5—atherosclerosis	1.2e-05	0.000234	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—FABP4—atherosclerosis	1.2e-05	0.000233	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LCAT—atherosclerosis	1.2e-05	0.000233	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.19e-05	0.000231	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.18e-05	0.00023	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.18e-05	0.00023	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA4—atherosclerosis	1.18e-05	0.000229	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LIPC—atherosclerosis	1.17e-05	0.000229	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.17e-05	0.000228	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOC3—atherosclerosis	1.17e-05	0.000227	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.17e-05	0.000227	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.16e-05	0.000227	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LIPC—atherosclerosis	1.16e-05	0.000227	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LDLR—atherosclerosis	1.16e-05	0.000226	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.16e-05	0.000225	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOC3—atherosclerosis	1.16e-05	0.000225	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.16e-05	0.000225	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.15e-05	0.000225	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.15e-05	0.000224	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SCARB1—atherosclerosis	1.15e-05	0.000224	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LDLR—atherosclerosis	1.15e-05	0.000224	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.14e-05	0.000222	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CETP—atherosclerosis	1.13e-05	0.000221	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.13e-05	0.00022	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.13e-05	0.00022	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.12e-05	0.000219	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CETP—atherosclerosis	1.12e-05	0.000219	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.12e-05	0.000217	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.11e-05	0.000217	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMGCR—atherosclerosis	1.09e-05	0.000212	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.08e-05	0.000211	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.07e-05	0.000209	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.07e-05	0.000209	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.07e-05	0.000208	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.06e-05	0.000207	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.05e-05	0.000204	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.05e-05	0.000204	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.03e-05	0.000201	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.02e-05	0.0002	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.02e-05	0.0002	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.02e-05	0.000199	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.01e-05	0.000198	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.01e-05	0.000198	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.01e-05	0.000197	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.01e-05	0.000197	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.01e-05	0.000197	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA2—atherosclerosis	1.01e-05	0.000197	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.01e-05	0.000197	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NAMPT—atherosclerosis	1e-05	0.000195	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCG5—atherosclerosis	1e-05	0.000195	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.94e-06	0.000194	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LIPC—atherosclerosis	9.94e-06	0.000194	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOC3—atherosclerosis	9.88e-06	0.000192	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LDLR—atherosclerosis	9.82e-06	0.000191	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—atherosclerosis	9.78e-06	0.000191	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ABCA1—atherosclerosis	9.68e-06	0.000189	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—F2—atherosclerosis	9.66e-06	0.000188	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPA—atherosclerosis	9.66e-06	0.000188	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CETP—atherosclerosis	9.59e-06	0.000187	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—HMOX1—atherosclerosis	9.53e-06	0.000186	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BGN—atherosclerosis	9.35e-06	0.000182	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA5—atherosclerosis	9.26e-06	0.00018	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	9.24e-06	0.00018	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.18e-06	0.000179	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.15e-06	0.000178	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOB—atherosclerosis	9.13e-06	0.000178	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCA1—atherosclerosis	9.12e-06	0.000178	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCA1—atherosclerosis	9.04e-06	0.000176	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.94e-06	0.000174	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.91e-06	0.000174	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—atherosclerosis	8.88e-06	0.000173	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	8.85e-06	0.000172	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—INS—atherosclerosis	8.75e-06	0.00017	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—LPL—atherosclerosis	8.72e-06	0.00017	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.67e-06	0.000169	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL2—atherosclerosis	8.61e-06	0.000168	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.61e-06	0.000168	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—atherosclerosis	8.51e-06	0.000166	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—atherosclerosis	8.46e-06	0.000165	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—atherosclerosis	8.31e-06	0.000162	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CD36—atherosclerosis	8.29e-06	0.000161	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	8.04e-06	0.000157	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOB—atherosclerosis	7.96e-06	0.000155	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—atherosclerosis	7.85e-06	0.000153	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.83e-06	0.000153	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.82e-06	0.000152	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.76e-06	0.000151	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—atherosclerosis	7.74e-06	0.000151	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.73e-06	0.000151	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.72e-06	0.00015	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARA—atherosclerosis	7.7e-06	0.00015	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—atherosclerosis	7.67e-06	0.00015	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LIPC—atherosclerosis	7.67e-06	0.000149	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOC3—atherosclerosis	7.62e-06	0.000149	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LPL—atherosclerosis	7.6e-06	0.000148	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LDLR—atherosclerosis	7.58e-06	0.000148	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOB—atherosclerosis	7.5e-06	0.000146	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AGT—atherosclerosis	7.46e-06	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOB—atherosclerosis	7.43e-06	0.000145	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—atherosclerosis	7.41e-06	0.000144	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CETP—atherosclerosis	7.4e-06	0.000144	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOE—atherosclerosis	7.31e-06	0.000142	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—atherosclerosis	7.29e-06	0.000142	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAV1—atherosclerosis	7.24e-06	0.000141	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.23e-06	0.000141	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOA1—atherosclerosis	7.23e-06	0.000141	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CD36—atherosclerosis	7.22e-06	0.000141	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LPL—atherosclerosis	7.16e-06	0.000139	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LPL—atherosclerosis	7.1e-06	0.000138	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.09e-06	0.000138	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—atherosclerosis	6.98e-06	0.000136	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—atherosclerosis	6.92e-06	0.000135	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—atherosclerosis	6.84e-06	0.000133	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	6.81e-06	0.000133	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CD36—atherosclerosis	6.8e-06	0.000133	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CD36—atherosclerosis	6.74e-06	0.000131	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARA—atherosclerosis	6.71e-06	0.000131	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.69e-06	0.00013	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.63e-06	0.000129	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—atherosclerosis	6.6e-06	0.000129	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	6.58e-06	0.000128	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AGT—atherosclerosis	6.5e-06	0.000127	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—atherosclerosis	6.47e-06	0.000126	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.45e-06	0.000126	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.39e-06	0.000124	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOE—atherosclerosis	6.37e-06	0.000124	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PPARG—atherosclerosis	6.37e-06	0.000124	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOB—atherosclerosis	6.35e-06	0.000124	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARA—atherosclerosis	6.32e-06	0.000123	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAV1—atherosclerosis	6.31e-06	0.000123	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOA1—atherosclerosis	6.3e-06	0.000123	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARA—atherosclerosis	6.27e-06	0.000122	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—INS—atherosclerosis	6.24e-06	0.000122	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.18e-06	0.00012	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—atherosclerosis	6.16e-06	0.00012	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AGT—atherosclerosis	6.12e-06	0.000119	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	6.09e-06	0.000119	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AGT—atherosclerosis	6.07e-06	0.000118	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LPL—atherosclerosis	6.06e-06	0.000118	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOE—atherosclerosis	6e-06	0.000117	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	5.99e-06	0.000117	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	5.97e-06	0.000116	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.96e-06	0.000116	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOE—atherosclerosis	5.95e-06	0.000116	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAV1—atherosclerosis	5.95e-06	0.000116	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOA1—atherosclerosis	5.93e-06	0.000116	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—atherosclerosis	5.92e-06	0.000115	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAV1—atherosclerosis	5.89e-06	0.000115	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOA1—atherosclerosis	5.88e-06	0.000115	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CD36—atherosclerosis	5.76e-06	0.000112	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.75e-06	0.000112	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—atherosclerosis	5.72e-06	0.000112	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PPARG—atherosclerosis	5.55e-06	0.000108	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	5.53e-06	0.000108	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—atherosclerosis	5.48e-06	0.000107	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—atherosclerosis	5.47e-06	0.000107	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.46e-06	0.000106	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—INS—atherosclerosis	5.44e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.42e-06	0.000106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.37e-06	0.000105	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARA—atherosclerosis	5.36e-06	0.000104	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	5.23e-06	0.000102	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PPARG—atherosclerosis	5.23e-06	0.000102	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AGT—atherosclerosis	5.19e-06	0.000101	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PPARG—atherosclerosis	5.18e-06	0.000101	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—INS—atherosclerosis	5.13e-06	9.99e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.12e-06	9.97e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOE—atherosclerosis	5.08e-06	9.9e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—INS—atherosclerosis	5.08e-06	9.9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	5.07e-06	9.89e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAV1—atherosclerosis	5.04e-06	9.81e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOA1—atherosclerosis	5.03e-06	9.79e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—atherosclerosis	5.01e-06	9.76e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—atherosclerosis	4.99e-06	9.72e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOB—atherosclerosis	4.9e-06	9.55e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—atherosclerosis	4.77e-06	9.29e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.77e-06	9.29e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—atherosclerosis	4.7e-06	9.16e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LPL—atherosclerosis	4.68e-06	9.12e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—atherosclerosis	4.66e-06	9.08e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.59e-06	8.94e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—atherosclerosis	4.57e-06	8.9e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—atherosclerosis	4.5e-06	8.76e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—atherosclerosis	4.46e-06	8.68e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CD36—atherosclerosis	4.45e-06	8.66e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPARG—atherosclerosis	4.43e-06	8.63e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—atherosclerosis	4.36e-06	8.5e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—INS—atherosclerosis	4.34e-06	8.46e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.21e-06	8.21e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARA—atherosclerosis	4.13e-06	8.06e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—atherosclerosis	4.11e-06	8.01e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.08e-06	7.94e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AGT—atherosclerosis	4e-06	7.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—atherosclerosis	3.98e-06	7.76e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOE—atherosclerosis	3.92e-06	7.64e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAV1—atherosclerosis	3.89e-06	7.57e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOA1—atherosclerosis	3.88e-06	7.56e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—atherosclerosis	3.82e-06	7.45e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—atherosclerosis	3.81e-06	7.42e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.54e-06	6.9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—atherosclerosis	3.53e-06	6.87e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.48e-06	6.79e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPARG—atherosclerosis	3.42e-06	6.66e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—INS—atherosclerosis	3.35e-06	6.53e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—atherosclerosis	3.07e-06	5.99e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—atherosclerosis	2.94e-06	5.73e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.69e-06	5.24e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—atherosclerosis	2.52e-06	4.9e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—atherosclerosis	2.19e-06	4.27e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—atherosclerosis	2.07e-06	4.03e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—atherosclerosis	2.05e-06	3.99e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—atherosclerosis	1.75e-06	3.41e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—atherosclerosis	1.35e-06	2.63e-05	CbGpPWpGaD
